Trial Profile
Telaprevir-based versus boceprevir-based triple therapy in patients with genotype 1 hepatitis C
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Mar 2014
Price :
$35
*
At a glance
- Drugs Boceprevir (Primary) ; Telaprevir (Primary) ; Peginterferon alfa-2a; Ribavirin
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 26 Mar 2014 New trial record